safety, tolerability, and monitoring

adverse events, boxed warnings, and what to track during treatment

safety, tolerability, and monitoring

semaglutide carries a well-characterized adverse event profile dominated by GI effects, a boxed warning for thyroid C-cell tumors in rodents, and ongoing surveillance for pancreatitis and lean mass loss. this unit walks through each risk category, the frequency data from pivotal trials, and the monitoring protocols that clinicians and informed users should follow.

use the free framing on this page to orient yourself, then unlock the deeper paid sections, quiz, and exercises for the full lesson.

Interactive Visualization

explore adverse event frequencies by severity and category across the semaglutide trial program.

adverse event frequency and severity matrix

Knowledge Check

test what you learned in this unit.

Practice Exercises

reinforce the safety and monitoring concepts before moving on.